¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Postprocedural disorders of circulatory system, NEC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® digestive system ÇÑ±Û ¼ÒÈ­±â°èÅë
¼³¸í   
  ¸ÔÀº À½½ÄÀÇ ºÐÇØ, ¼ÒÈ­, Èí¼ö¿¡ °ü°èµÈ Àå±â¸¦ ÅëÄªÇØ¼­ ºÎ¸£´Â ¸».
¿µ¹® nervous system ÇÑ±Û ½Å°æ°è
¼³¸í   
  ¿©·¯ ±â°üµéÀÇ ¼­·Î°£ »óÈ£¿¬°áü°è°¡ ¹Ù·Î ½Å°æ°èÀÌ´Ù. ¿©±â¿¡´Â ÁßÃ߽Űæ°è(central nerve system: CNS)¿Í ¸»ÃʽŰæ°è(peripheral nerve system: PNS)°¡ Àִµ¥, ÁßÃ߽Űæ°è¶õ ³ú¿Í Ã´¼ö¸¦ ¸»ÇÑ´Ù. ±×¸®°í ¸»ÃʽŰæ°è¿¡´Â 12½ÖÀÇ ³ú½Å°æ(cranial nerve: ³ú¿¡¼­ ±â½ÃÇÏ¿© ÁַΠ¾ó±¼ºÎÀ§¿Í ¸ñ ºÎÀ§¿¡ ºÐÆ÷ÇÑ´Ù)°ú 31½ÖÀǠô¼ö½Å°æ(spinal nerve:spinal cord¿¡¼­ °¢±â ¾çÂÊÀ¸·Î ½ÖÀ» ÀÌ·ç¾î ³ª¿À´Âµ¥ ÁַΠ¸ñÀÌÇϺÎÀ§ÀÇ ½Åü °¢ºÎºÐÀ¸·Î ºÐÆ÷ÇϰԠµÈ´Ù)À¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
  
  ¶ÇÇÑ ¸»ÃʽŰæ°è´Â 3°¡ÁöÀÇ ½Å°æÁ¶Á÷µé·Î ±¸¼ºµÇ¾î Àִµ¥ ¾Õ¿¡¼­ ¸»ÇÑ ³ú½Å°æ°ú Ã´¼ö½Å°æ¿Ü¿¡ ÀÚÀ²½Å°æ°è°¡ ¿©±â¿¡ ÇØ´çµÈ´Ù. ÀÚÀ²½Å°æ°è´Â ´Ù½Ã ±³°¨½Å°æ°ú ºÎ±³°¨½Å°æÀ¸·Î ³ª´µ¾îÁ® ¼­·Î°£ÀÇ ¿Ã¹Ù¸¥ »óÈ£ÀÛ¿ëÀ¸·Î »ýü ¿©·¯ °¡Áö ÀÛ¿ëÀ» ¼öÇàÇÑ´Ù.
¿µ¹® cardiovascular system ÇÑ±Û ½ÉÀåÇ÷°ü°è
¼³¸í   
  ½ÅüÀÇ Ç÷¾×¼øÈ¯À» ´ã´çÇϴ ±â°ü. Áï ½ÉÀå°ú Ç÷°üÀ» ÅëÄªÇØ¼­ À̸£´Â ¸»ÀÌ´Ù.
¿µ¹® autonomic nervous system ÇÑ±Û ÀÚÀ²½Å°æ°è
¼³¸í   
  »ç¶÷ÀÇ ÀÇÁö¿Í °ü°è¾øÀÌ, Ä§À» È긮°Å³ª ¼ÒÈ­¿îµ¿ µî°ú °°Àº ½º½º·Î Á¶Á¤ÀÌ µÇ¾î ¿òÁ÷À̴ ½Å°æ°èÀ̸砿©±â¿¡´Â ´ÙÀ½°ú °°Àº µÎ °¡Áö°¡ ÀÖ´Ù.
  
  1.±³°¨½Å°æ°è(sympathetic nervous system)-»ç¶÷ÀÌ À§Çè»óÅ¿¡ À̸£·¶À» °æ¿ì¿¡ ÈïºÐÀÌ µÇ´Â ÀÚÀ²½Å°æ°è. ÁɹڼöÀÇ Áõ°¡, ¼ÒÈ­±â ¿îµ¿ÀÇ °¨¼Ò µîÀÇ ÀÏÀÌ À̰÷À» ÅëÇØ¼­ ÀϾ´Ù. ±³°¨½Å°æÀÌ ÈïºÐµÇ¸é ±³°¨½Å°æÀÇ ¸»´Ü¿¡¼­ epinephrine, norepinephrine µîÀÇ ¹°ÁúÀÌ ºÐºñµÇ°í À̰͵鿡 ÀÇÇØ¼­ ¸»ÃÊÀå±â°¡ º¯È­¸¦ ÀÏÀ¸Å²´Ù. ÇÏÁö¸¸ Àå±â¿¡ µû¶ó¼­ epinephrineÀ̳ª norepinephrineÀÇ ¼ö¿ëü¸¦ °¡Áö°í À־ ¿©·¯ °¡Áö ´Ù¸¥ Àå±âÀÇ ¹ÝÀÀÀ» º¼ ¼ö°¡ ÀÖ´Ù. ¼ö¿ëü´Â ´ÙÀ½°ú °°´Ù.
  
    -¾ËÆÄ¼ö¿ëü(alpha-receptor): ¸»ÃÊÇ÷°üÀÇ ¼öÃà, ±â°üÁöÀÇ ¼öÃà, µ¿°øÀÇ ±ÙÀ°ÀÇ ¼öÃà
  
    -º£Å¸1¼ö¿ëü(beta 1-receptor): ½ÉÀå¿¡ Á¸ÀçÇϴ ¼ö¿ëü, ½ÉÀåÀ» »¡¸® ¶Ù°ÔÇϴ ¿ªÇÒÀ» ÇÑ´Ù.
  
    -º£Å¸2¼ö¿ëü(beta 2-receptor): Ç÷°üÀÇ ÀÌ¿Ï, ±â°üÁöÀÇ ÀÌ¿Ï, Áï °¢ Àå±âµéÀº ±× Àå±â°¡ °¡Áö°í Àִ ±³°¨½Å°æÀÇ ¼ö¿ëü¿¡ µû¶ó ±³°¨½Å°æÀÇ ÈïºÐ(±³°¨½Å°æ ¸»´Ü¿¡¼­ÀÇ epinephrineÀÇ ºÐºñ)¿¡ ´ëÇÑ ¹ÝÀÀÀÌ ´Þ¶óÁø´Ù(¿¹-±³°¨½Å°æÀÌ ÈïºÐ½Ã¿¡ beta 1-¼ö¿ëü¸¦ °¡Áö°í Àִ ½ÉÀåÀº »¡¸® ¶Ù°Ô µÈ´Ù. ±³°¨½Å°æ ÈïºÐ½Ã¿¡ µ¿°øÀÇ ±ÙÀ°ÀÌ ¼öÃàÇØ¼­ µ¿°øÀÇ Å©±â°¡ Ä¿Áø´Ù)
  
  2.ºÎ±³°¨½Å°æ°è(parasympathetic nervous system)-±³°¨½Å°æ°ú ¹Ý´ë·Î ÀÛ¿ëÇÑ´Ù. Áï »ç¶÷ÀÌ Á¹¸®°Å³ª ½¯ °æ¿ì¿¡ ÈïºÐÇÑ´Ù. ºÎ±³°¨½Å°æÀÌ ÈïºÐÇÒ ¶§¿¡´Â ½Å°æÀÇ ¸»´Ü¿¡¼­ ¾Æ¼¼Ä¥Äݸ°ÀÇ ºÐºñ°¡ ÀϾ°í À̰ÍÀ¸·Î ÀÎÇØ¼­ °¢ Àå±âÀÇ º¯È­°¡ ÀϾ´Ù.
¿µ¹® TNM staging system ÇÑ±Û Á¾¾çº´±âºÐ·ù°èÅë
¼³¸í   
  Á¾¾çÀÇ º´±â(stage)¸¦ °áÁ¤Çϴ ÇÑ ¹æ¹ý.
  
  T´Â Tumor(Á¾¾ç)¸¦ ¶æÇϸ砿ø¹ßº´ÅÍÀÇ Å©±â, ÁÖÀ§Á¶Á÷À¸·ÎÀǠħÀ±Á¤µµ µî¿¡ µû¶ó T1, T2, T3, T4(¼ýÀÚ°¡ ³ôÀ» ¼ö·Ï ÁÖÀ§·Î Ä§À±ÀÌ ¸¹´Ù) µîÀ¸·Î ³ª´«´Ù.
  
  NÀº Node(¸²ÇÁÀý)¸¦ ¶æÇϸç Ä§¹üµÈ ¸²ÇÁÀýÀÇ °¹¼ö, Å©±â, À§Ä¡ µî¿¡ µû¶ó N1, N2, N3 µîÀ¸·Î ³ª´«´Ù.
  
  MÀº Metastasis(ÀüÀÌ)¸¦ ¶æÇϸ砿ø°ÝÀüÀÌÀÇ À¯¹«¿¡ µû¶ó M0, M1 µîÀ¸·Î ³ª´«´Ù.
  
  ÀÌ»óÀÇ ¹æ¹ýÀ¸·Î T, N, MÀÌ °áÁ¤µÇ¸é À̵éÀ» Á¶ÇÕÇÏ¿© ÃÖÁ¾ÀûÀΠº´±â¸¦ °áÁ¤ÇÑ´Ù. ÀÌ·¸°Ô °áÁ¤µÈ º´±â´Â Ä¡·á ¹æÄ§ °áÁ¤°ú ¿¹ÈÄ ÆÇ´Ü¿¡ ¸Å¿ì Áß¿äÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • case payment system
    Æ÷°ý¼ö°¡Á¦
  • central nervous system
    ÁßÃ߽Űæ°èÅë, ÁßÃ߽Űæ°è
  • drug delivery system
    ¾à¹°Àü´Þü°è
  • dynamic system
    µ¿Àû°èÅë
  • digestive system
    ¼ÒÈ­°èÅë, ¼ÒÈ­°è
  • display system
    Ç¥½ÃÀåÄ¡
  • exteroceptive nervous system
    ¿Ü¼ö¿ë½Å°æ°è
  • extrapyramidal motor system
    ÇǶó¹Ìµå¹Ù±ù±æ¿îµ¿°è, Ãßü¿Ü·Î¿îµ¿°è
  • electro-optical system
    Àü±â±¤Çкм®°è
  • emergency medical service system
    ÀÀ±ÞÀÇ·á¼­ºñ½ºÃ¼°è
  • endocrine system
    ³»ºÐºñ°èÅë, ³»ºÐºñ°è
  • ecological system
    »ýŰè
  • family system theory
    °¡Á·Ã¼°è·Ð
  • gate control system
    °ü¹®Á¶Á¤ÀåÄ¡
  • general system theory
    ÀϹÝü°è·Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • central piping system
    Áß¾Ó¹è°ü½Ã¼³
  • chemoreception system
    È­Çмö¿ë°è
  • circle absorption system
    ¼øÈ¯Èí¼ö½Äȸ·Î
  • circuit system
    ¼øÈ¯½Äȸ·Î
  • closed drainage system
    ´ÝÈû¹èÃâÀåÄ¡
  • clotting system
    ÀÀ°í°èÅë
  • collecting system
    ÁýÇÕ°è
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • community water system
    Áö¿ª»çȸ±Þ¼ö½Ã¼³
  • complement system
    µµ¿òü°èÅë, º¸Ã¼°èÅë
  • conduction system
    ÈïºÐÀüµµ°è
  • control system
    Á¦¾îÀåÄ¡
  • cortically originating extrapyamidal system
    °ÑÁú±â¿øÇǶó¹Ô¹Ù±ù·Î°èÅë, ÇÇÁú¹ßÃßü¿Ü·Î°è
  • countercurrent system
    ¿ª·ù°è
  • countercurrent exchanger system
    ¿ª·ù±³È¯°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Haversian system
    »À ´ÜÀ§<°ñ¿ø>, ÇϹö½º °èÅë(¡­Í§÷Ö).
  • Haversian system
    »À´ÜÀ§<°ñ¿ø>, ÇϹö½º°è Åë(¡­Í§÷Ö).
  • Haversian system
    ÇϹö½º°è
  • Hypothalamic-hypophysial portal system
    ½Ã»óÇϺÎ-Çϼöü ¹®¸Æ°è(ãÊßÉù»Ý» ù»á÷ô÷ Ú¦ØæÍ§)
  • Immune system
    ¸é¿ªÃ¼°è(Øóæ¹ô÷ͧ)
  • International System of Unit
    ±¹Á¦´ÜÀ§°è
  • Jackson-Rees anesthetic circuit system
    Àè½¼-¸® ¸¶ÃëÀåÄ¡
  • Kell blood group system
    ÄÌÇ÷¾×Çü±º
  • Kell system
    ÄÌÇ÷¾×Çü.
  • Kidd blood group system
    ۵åÇ÷¾×Çü±º
  • Lewis blood group system
    ·çÀ̽º Ç÷¾×Çü±º
  • Lutheran blood group system
    ·çÅͶõ Ç÷¾×Çü±º
  • Lymphatic system
    ¸²ÇÁ°è(¡­Í£)
  • Magills anesthetic circuit system
    ¸¶Áú¸¶ÃëÀåÄ¡
  • Mapleson anesthetic circuit system
    ¸ÅÇý¼¸¶Ãëȸ·Î
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cytogenetic disorders
    ¼¼Æ÷À¯ÀüÀå¾Ö(¡­ë¶îîî¡äô)
  • diaphragm disorders
    Ⱦ°æ¸·ÀÌ»ó
  • disorders of articulation
    ±³ÇÕÀå¾Ö(Îáùê î¡äô).
  • disorders of sensation
    Áö°¢Àå¾Ö(ò±ÊÆî¡äô).
  • electrolyte disorders
    ÀüÇØÁúÀÌ»ó(ï³ú°òõì¶ßÒ).
  • electrolyte disorders
    ÀüÇØÁúÀÌ»ó.
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • larynx, congenital disorders of the
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • mendelian disorders
    ¸àµ¨ À¯Àü¼º Áúȯ(¡­ë¶îîàõ òðü´)
  • monoarticular disorders
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • isolated system
    °Ý¸®(̰×î)½Ã½ºÅÛ
  • Kovats retention index system
    ÄÚ¹ÙÆ® ü·ù(ôò׺) Áö¼ö(ò¦â¦)½Ã½ºÅÛ
  • K system
    K ½Ã½ºÅÛ
  • leiotonin system
    ¶óÀÌ¿ÀÅä´Ñ ½Ã½ºÅÛ
  • MN blood group system
    MN½Ä(ãÒ)Ç÷¾×Çü(úìäûúþ)
  • model system
    ¸ðµ¨½Ã½ºÅÛ
  • multienzyme system
    ´ÙÈ¿¼Ò(Òýý£áÈ)½Ã½ºÅÛ
  • multisubstrate enzyme system
    ´Ù±âÁúÈ¿¼Ò(ÒýѨòõý£áÈ) ½Ã½ºÅÛ
  • open-circuit system
    °³¹æÈ¸·Î(ËÒÛ¯üÞÖØ) ½Ã½ºÅÛ
  • open system
    °³¹æ(ËÒÛ¯) ½Ã½ºÅÛ
  • optical system
    ±¤(ÎÃ) ½Ã½ºÅÛ
  • phosphotransferase system
    Æ÷½ºÆ÷Æ®¶õ½ºÆÛ·¹À̽º ½Ã½ºÅÛ
  • protein-synthesizing system
    ´Ü¹éÁú ÇÕ¼º(Ó±ÛÜòõùêà÷) ½Ã½ºÅÛ
  • repressible system
    ¾ïÁ¦¼º ½Ã½ºÅÛ
  • restriction-modification system
    Á¦ÇÑ ¼ö½Ä(áóãÞ) ½Ã½ºÅÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TCA T-cell A locus; terminal cancer; tetracyclic antidepressant; total cholic acid; total circulating al...
GDS geriatric depression scale; Global Deterioration Scale; Gordon Diagnostic System [for attention diso...
MDS Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system...
MPS meconium plug syndrome; medial premotor system; Member of the Pharmaceutical Society; microbial prof...
ASDC Association of Sleep Disorders Centers; ¹Ì±¹ ¼ö¸é Áúȯ ¼¾ÅÍ Çùȸ
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ACD Anemia of chronic disorders
BLPD B cell lympho-proliferative disorders
CAMDEX Cambridge Mental Disorders of the Elderly Examination
CMPD Chronic myeloproliferative disorders
CDG Congenital Disorders of Glycosylation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • combined system disease
    º¹ÇÕ °èÅë Áúȯ
  • concise enamel bond system
    ´Ü¼ø ¹ý¶ûÁú °áÇÕ
  • condensed system
    ÀÀ»ó°è
  • conduction system
    ÈïºÐ Àüµµ°è
  • control system
    Á¶Àý°è
  • corticospinal system
    ÇÇÁú ô¼ö°è
  • countercurrent system
    ¿ª·ù°è, ´ëÇâ·ù°è
  • crystal system
    Á¤°è, °áÁ¤°è
  • cyclic AMP system
    ȯ»ó AMP °è
  • descending inhibitory system
    ÇÏÇà ¾ïÁ¦°è
  • digestive system
    ¼ÒÈ­±â °èÅë
  • disease of the lymphreticular system
    ¸²ÇÁ ¼¼¸Á³»ÇǰèÀÇ Áúȯ
  • DNA repair system
    DNA º¸¼ö ±â±¸
  • dopaminergic system
    µµÆÄ¹Î ü°è
  • drug delivery system
    ¾à¹° Åõ¿©±â, ¾à¹° Åõ¿© üÁ¦, ¾à¹° Àü´Þ ü°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
personality disorders A major deviation from normal patterns of behaviour.
(12 Dec 1998)
growth disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth.
(12 Dec 1998)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ciliary motility disorders Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.
(12 Dec 1998)
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
platelet function disorders <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(31 Dec 1997)
multifactorial or multigenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
consciousness disorders Organic mental disorders in which there is marked impairment of awareness.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • container system
    ÄÁÅ×ÀÌ³Ê ¼ö¼Û¹æ½Ä
  • convict system
    ¡¿ª(À¯Çü)Á¦µµ
  • coupon system
    °æÇ°ºÎ ÆÇ¸Å¹ý
  • data base management system
    (Àü»ê)µ¥ÀÌÅͺ£À̽º °ü¸® ½Ã½ºÅÛ(¾à DBMS)
  • decimal system
    ½ÊÁø¹ý
  • decision support system
    (Àü»ê)(°æ¿µÀÇ)ÀÇ»ç °áÁ¤ Áö¿ø ½Ã½ºÅÛ
  • delayed time system
    (ÀüÀÚ)½Ã°£ Áö¿¬(ÃàÀû)¹æ½Ä
  • digestive system
    (ÇØ)¼ÒÈ­±â °èÅë(ÀÔ,À§,Àå µî)
  • domestic system
    °¡³» °ø¾÷ Á¦µµ
  • duples system
    (Àü»ê)º¹½Ä ½Ã½ºÅÛ(2´ëÀÇ ÄÄÇ»Å͸¦ ¼³Ä¡Ç쵂 Çϳª´Â ¿¹ºñ¿ë)
  • early-warning system
    (±º)(ÇÙ°ø°Ý¿¡ ´ëÇÑ)Á¶±â °æº¸ Á¶Á÷
  • factory system
    °øÀå Á¦µµ
  • farm system
    Á¦2±º ¸®±× ÇÕµ¿ ¿î¿µÁ¦
  • feudal system
    ºÀ°Ç Á¦µµ
  • fixed exchange rate(system)
    °íÁ¤È¯½Ã¼¼(Á¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á